Literature DB >> 5497802

Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart.

L L Iversen, P J Salt.   

Abstract

Various steroids (17-beta-oestradiol, corticosterone, deoxycorticosterone, progesterone, testosterone and androsterone) produced a dose-dependent inhibition of the uptake of (3)H-noradrenaline by the Uptake(2) mechanism in the isolated perfused heart. It is suggested that these results may explain the potentiating effects of such steroids on the responses of vascular smooth muscle to catecholamines.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5497802      PMCID: PMC1703119          DOI: 10.1111/j.1476-5381.1970.tb10637.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  A UNIFIED THEORY OF GLUCOCORTICOID ACTION.

Authors:  R W SCHAYER
Journal:  Perspect Biol Med       Date:  1964       Impact factor: 1.416

2.  The influence of the adrenal cortex on behavior of terminal vascular bed.

Authors:  B W ZWEIFACH; E SHORR; M M BLACK
Journal:  Ann N Y Acad Sci       Date:  1953-07-17       Impact factor: 5.691

3.  Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta.

Authors:  S Kalsner
Journal:  Circ Res       Date:  1969-03       Impact factor: 17.367

4.  The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart.

Authors:  S L Lightman; L L Iversen
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

5.  Steroid potentiation of responses to sympathomimetic amines in aortic strips.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

  5 in total
  92 in total

1.  Pituitary-adrenal dynamics after ACTH-secreting pituitary tumor resection in patients receiving no steroids post-operatively.

Authors:  F R Pimentel-Filho; M E R Silva; K C Nogueira; K Berger; A Cukiert; B Liberman
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

2.  Effect of isoprenaline on noradrenaline release from sympathetic neurones in rabbit isolated pulmonary artery.

Authors:  O A Nedergaard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

3.  The influence of amine metabolizing enzymes on the pharmacology of tyramine in the isolated perfused mesenteric arterial bed of the rat.

Authors:  J Elliott; B A Callingham; D F Sharman
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  The effects of hypercholesterolaemic plasma on vascular sensitivity to noradrenaline.

Authors:  D Bloom; T A McCalden; C Rosendorff
Journal:  Br J Pharmacol       Date:  1975-08       Impact factor: 8.739

5.  The effect of reserpine treatment on the extraneuronal uptake of [3H]-isoprenaline into rat atria.

Authors:  A J Morton
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

6.  An uptake mechanism for L-noradrenaline in the cat spleen, associated with the nerves but distinct from uptake.

Authors:  A G Blakeley; G Powis; R J Summers
Journal:  J Physiol       Date:  1974-04       Impact factor: 5.182

7.  The influence of hormonal and neuronal factors on rat heart adrenoceptors.

Authors:  G Kunos; L Mucci; S O'Regan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine.

Authors:  L L Iversen; P J Salt; H A Wilson
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  The influence of oestrogen and oestrogen metabolites on the sensitivity of the isolated rabbit aorta to catecholamines.

Authors:  S Barone; D Panek; L Bennett; R E Stitzel; R J Head
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

10.  The effects of jaundiced plasma and hypercholesterolaemic plasma on vascular sensitivity to injected noradrenaline.

Authors:  T A McCalden; D Bloom; C Rosendorff
Journal:  Experientia       Date:  1975-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.